Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Metylenblått hävde metformin­associerad laktacidos. Gav dramatiskt positiv effekt vid samtidig vasodilatorisk chock
Engelsk titel: Methylene blue stopped metformin-associated lactic acidosis and refractory vasodilatation. Läs online Författare: Höjer, Jonas ; Westerbergh, Jenny ; Edfeldt-Ugarph, Malin ; Johansson, Åsa Språk: Swe Antal referenser: 21 Dokumenttyp: Fallbeskrivning UI-nummer: 13117057

Tidskrift

Läkartidningen 2013;110(42)1865-6 ISSN 0023-7205 E-ISSN 1652-7518 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

A case of metformin-associated lactic acidosis and refractory vasodilatation treated with methylene blue and a literature review are presented. An adult on metformin treatment presented awake with shortness of breath. His BP was 160/100 mm Hg and pulse 100 bpm. Arterial blood gas analysis displayed pH 6.9, BE –30 and lactate 18 mmol/l. S-creatinine was 832 µmol/l. He suddenly deteriorated with a severe fall in blood pressure and was acutely intubated. At the ICU, echocardiography and hemodynamic measurements showed slightly decreased myocardial contractility and a very low systemic vascular resistance. Despite treatment with fluids, sodium bicarbonate, 3 vasopressor agents and CVVDH, the mean arterial pressure (MAP) was <50 mm Hg and lactate severely elevated for 20 hours. Methylene blue was then given as a bolus of 1.3 mg/kg iv followed by an infusion of 0.1 mg/kg/h. The effect was remarkable. Within 15 minutes, MAP increased by 15 mm Hg and lactate started to decrease. The patient recovered. Methylene blue may be effective in metformin-induced refractory vasodilatory shock.